Published in Antimicrob Agents Chemother on February 01, 1978
Antibiotic prophylaxis in vascular surgery. Ann Surg (1978) 1.97
Efficacy of cefazolin, cefamandole, and gentamicin as prophylactic agents in cardiac surgery. Results of a prospective, randomized, double-blind trial in 1030 patients. Ann Surg (1987) 1.01
Comparative prophylactic efficacies of ciprofloxacin, ofloxacin, cefazolin, and vancomycin in experimental model of staphylococcal wound infection. Antimicrob Agents Chemother (1994) 0.91
Antibiotic prophylaxis in craniotomy: a review. Neurosurg Rev (2014) 0.75
Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol (1966) 159.00
Simple agarose gel electrophoretic method for the identification and characterization of plasmid deoxyribonucleic acid. J Bacteriol (1976) 43.93
Pseudomonas aeruginosa resistant to carbenicillin and gentamicin. Epidemiologic and clinical aspects in a cancer center. Ann Intern Med (1973) 3.81
Prosthetic valve endocarditis. Analysis of 38 cases. Circulation (1973) 3.29
Serratia marcescens infections from inhalation therapy medications: nosocomial outbreak. Ann Intern Med (1970) 2.94
Prosthetic valvular endocarditis. A 12-year review. Circulation (1973) 2.71
Colonization with gentamicin-resistant Pseudomonas aeruginosa, pyocine type 5, in a burn unit. J Infect Dis (1971) 2.36
Gentamicin-resistant Pseudomonas aeruginosa and Serratia marcescens in a general hospital. Lancet (1976) 2.07
Serratia marcescens septicemia. A new threat in surgery. Arch Surg (1969) 2.04
Emergence of gentamicin-resistant Klebsiella in a general hospital. Antimicrob Agents Chemother (1977) 1.96
An outbreak of nosocomial infection due to multiply resistant Serratia marcescens: evidence of interhospital spread. J Infect Dis (1976) 1.95
Outbreak of a nosocomial infection with a strain of Proteus rettgeri resistant to many antimicrobials. Am J Clin Pathol (1974) 1.95
Nosocomial urinary tract infection with Serratia marcescens: an epidemiologic study. J Infect Dis (1973) 1.95
Microbiologic studies related to bacterial resistance to gentamicin. J Infect Dis (1971) 1.91
Prosthetic valve endocarditis. Ann Intern Med (1975) 1.78
A hospital outbreak of Serratia marcescens associated with ultrasonic nebulizers. Ann Intern Med (1968) 1.76
Amikacin therapy for serious gram-negative bacillary infections. Ann Intern Med (1975) 1.70
Serratia marcescens. A pathogen of increasing clinical importance. JAMA (1970) 1.62
Antibiotic prophylaxis and cardiac surgery. A prospective double-blind comparison of single-dose versus multiple-dose regimens. Ann Intern Med (1972) 1.54
Antibiotic resistance patterns of clinical isolates of Serratia marcescens. Antimicrob Agents Chemother (1975) 1.38
Nosocomial infections due to Pseudomonas. J Infect Dis (1974) 1.34
Multidrug-resistant Proteus rettgeri: an emerging problem. Ann Intern Med (1976) 1.27
Diagnosis and management of complications of prosthetic heart valves. Am J Cardiol (1975) 1.23
Prosthetic valve endocarditis. J Thorac Cardiovasc Surg (1970) 1.16
Sulfamethoxazole-trimethoprim-polymyxin therapy of serious multiply drug-resistant Serratia infections. Antimicrob Agents Chemother (1976) 1.11
Nosocomial infection with highly resistant, Proteus rettgeri. Report of an epidemic. Am J Epidemiol (1976) 1.06
Antibiotic usage and microbial resistance in an intensive care nursery. Am J Dis Child (1973) 1.06
Nosocomial infection with gentamicin-carbenicillin-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother (1976) 1.04
Prosthetic cardiac valves and bacterial endocarditis. Ann Thorac Surg (1970) 1.02
Prevention of catheter-associated urinary tract infection. An additional measure. JAMA (1972) 0.95
R factor-mediated antibiotic resistance in Serratia marcescens. Antimicrob Agents Chemother (1976) 0.93
Virulence in rats of gentamicin-carbenicillin-resistant Pseudomonas. Antimicrob Agents Chemother (1975) 0.92
Prosthetic aortic valvular endocarditis. Circulation (1975) 0.90
Ecology of staphylococci in a general medical service. Appl Microbiol (1972) 0.89
Experience with detailed surveillance of nosocomial infection. Surg Gynecol Obstet (1975) 0.88
Serratia marcescens as a postoperative pathogen. Am J Surg (1971) 0.86
Susceptibilities of bacteria to different antibiotic regimens. Study in two nursery populations. Am J Dis Child (1975) 0.86
Clinically useful method for the isolation of respiratory syncytial virus. J Infect Dis (1975) 5.00
Generation and maintenance of gradients in taxonomic diversity. Science (1969) 4.33
A prospective study of chronic herpes simplex virus infection and recurrent herpes labialis in humans. J Immunol (1970) 4.12
Plaque inhibition assay for drug susceptibility testing of influenza viruses. Antimicrob Agents Chemother (1980) 3.60
Assessing illness severity: does clinical judgment work? J Chronic Dis (1986) 2.82
Assessment of experimental and natural viral aerosols. Bacteriol Rev (1966) 2.64
Successful treatment of naturally occurring influenza A/USSR/77 H1N1. JAMA (1981) 2.50
New vaccine technologies. JAMA (1994) 2.45
Respiratory syncytial virus infections in infants: quantitation and duration of shedding. J Pediatr (1976) 2.45
Evaluation of influenza A/Hong Kong/123/77 (H1N1) ts-1A2 and cold-adapted recombinant viruses in seronegative adult volunteers. Infect Immun (1980) 2.42
Effect of route of inoculation on experimental respiratory viral disease in volunteers and evidence for airborne transmission. Bacteriol Rev (1966) 2.41
QacR is a repressor protein that regulates expression of the Staphylococcus aureus multidrug efflux pump QacA. J Biol Chem (1998) 2.31
Morbidity during hospitalization: can we predict it? J Chronic Dis (1987) 2.21
Correlated studies of a recombinant influenza-virus vaccine. 3. Protection against experimental influenza in man. J Infect Dis (1971) 2.13
Temperature-sensitive mutants of influenza A virus. XII. Safety, antigenicity, transmissibility, and efficacy of influenza A/Udorn/72-ts-1[E] recombinant viruses in human adults. J Infect Dis (1976) 2.12
The role of nasal secretion and serum antibody in the rhinovirus common cold. Am J Epidemiol (1966) 2.11
Interferon production in children with respiratory syncytial, influenza, and parainfluenza virus infections. J Pediatr (1978) 2.01
Viral shedding patterns of children with influenza B infection. J Infect Dis (1979) 1.91
A nurse led intermediate care package in patients who have been hospitalised with an acute exacerbation of chronic obstructive pulmonary disease. Thorax (2007) 1.89
Possible transmission by fomites of respiratory syncytial virus. J Infect Dis (1980) 1.87
Nosocomial respiratory syncytial virus infections. N Engl J Med (1975) 1.85
Modes of transmission of respiratory syncytial virus. J Pediatr (1981) 1.84
Neonatal respiratory syncytial virus infection. N Engl J Med (1979) 1.82
Double-blind evaluation of oral ribavirin (Virazole) in experimental influenza A virus infection in volunteers. Antimicrob Agents Chemother (1977) 1.70
Comparative activity of immunofluorescent antibody and complement-fixing antibody in cytomegalovirus infection. J Clin Microbiol (1976) 1.64
Airway hyperreactivity and peripheral airway dysfunction in influenza A infection. Am Rev Respir Dis (1978) 1.62
Clinical manifestations of renal allograft derived primary cytomegalovirus infection. Am J Dis Child (1977) 1.60
Rhinovirus neutralizing antibody in tears, parotid saliva, nasal secretions and serum. J Immunol (1967) 1.59
Amantadine effect on peripheral airways abnormalities in influenza. A study in 15 students with natural influenza A infection. Ann Intern Med (1976) 1.52
Infectivity of respiratory syncytial virus by various routes of inoculation. Infect Immun (1981) 1.50
Changes in IgA and IgG concentrations in nasal secretions prior to the appearance of antibody during viral respiratory infection in man. J Immunol (1970) 1.49
Nosocomial influenza infection as a cause of intercurrent fevers in infants. Pediatrics (1975) 1.46
Genetic evaluation of suspected cases of transient HIV-1 infection of infants. Science (1998) 1.43
Virus-induced interferon production by human macrophages. J Immunol (1979) 1.42
Amantadine therapy of epidemic influenza a(2) (Hong Kong). Infect Immun (1970) 1.39
Temperature-sensitive mutants of influenza A virus: evaluation of the Alaska/77-ts-1A2 temperature-sensitive recombinant virus in seronegative adult volunteers. Arch Virol (1980) 1.39
Human alveolar macrophage support of lymphocyte responses to mitogens and antigens. Analysis and comparison with autologous peripheral-blood-derived monocytes and macrophages. Am Rev Respir Dis (1983) 1.37
Pathogenesis of rhinovirus common colds in human voluteers. Ann Otol Rhinol Laryngol (1970) 1.37
Respiratory syncytial virus and influenza. Practical community surveillance. Am J Dis Child (1976) 1.36
Temperature and host defense. Microbiol Rev (1979) 1.35
A nod factor binding lectin with apyrase activity from legume roots. Proc Natl Acad Sci U S A (1999) 1.35
Relation of chronic disease and immune response to influenza vaccine in the elderly. Vaccine (1989) 1.35
Attenuated influenza produced by experimental intranasal inoculation. J Med Virol (1979) 1.33
Clinical assessments as predictors of one year survival after hospitalization: implications for prognostic stratification. J Clin Epidemiol (1988) 1.32
Detection of rare mutant alleles by restriction endonuclease-mediated selective-PCR: assay design and optimization. Clin Chem (2000) 1.32
Responses of elderly subjects to monovalent A/USSR/77 (H1N1) and Trivalent A/USSR/77 (H1N1)-A/TEXAS/77 (H3N2)-B/Hong Kong/72 vaccines. Am Rev Respir Dis (1981) 1.31
Human lymphocyte apoptosis after exposure to influenza A virus. J Virol (2001) 1.31
Temperature-sensitive mutants of influenza A virus: evaluation of A/Victoria/3/75-ts-1[E] recombinant viruses in volunteers. Infect Immun (1978) 1.30
Effect of in vitro virus infection on response of human monocytes and lymphocytes to mitogen stimulation. J Immunol (1978) 1.30
Effects of ribavirin on respiratory syncytial virus in vitro. Antimicrob Agents Chemother (1980) 1.28
Quantitative shedding patterns of respiratory syncytial virus in infants. J Infect Dis (1975) 1.28
Airborne transmission of respiratory infection with coxsackievirus A type 21. Am J Epidemiol (1970) 1.28
Enhancement of activity against influenza viruses by combinations of antiviral agents. Antimicrob Agents Chemother (1980) 1.28
Interferon and resistance to upper respiratory virus illness. Proc Soc Exp Biol Med (1969) 1.27
Evaluation of A/Alaska/6/77 (H3N2) cold-adapted recombinant viruses derived from A/Ann Arbor/6/60 cold-adapted donor virus in adult seronegative volunteers. Infect Immun (1981) 1.27
Airway reactivity in subjects with viral upper respiratory tract infections: the effects of exercise and cold air. Am Rev Respir Dis (1980) 1.27
Mortality among males in periodic-health-examination programs. N Engl J Med (1969) 1.27
Quantitative rhinovirus shedding patterns in volunteers. Am Rev Respir Dis (1966) 1.27
Significance of Herpesvirus hominis in respiratory secretions of man. N Engl J Med (1968) 1.26
Vaccination of vaccinia-naive adults with human immunodeficiency virus type 1 gp160 recombinant vaccinia virus in a blinded, controlled, randomized clinical trial. The AIDS Vaccine Clinical Trials Network. J Infect Dis (1992) 1.25
Malignant external otitis: a severe form of otitis in diabetic patients. Am J Med (1976) 1.23
Hyperthermia and human leukocyte functions: effects on response of lymphocytes to mitogen and antigen and bactericidal capacity of monocytes and neutrophils. Infect Immun (1977) 1.20
Different effects of influenza virus, respiratory syncytial virus, and Sendai virus on human lymphocytes and macrophages. Infect Immun (1982) 1.19
The use of eye-nose goggles to control nosocomial respiratory syncytial virus infection. JAMA (1986) 1.16
Respiratory syncytial virus infection of human mononuclear leukocytes in vitro and in vivo. J Infect Dis (1985) 1.16
Reduction in fever and symptoms in young adults with influenza A/Brazil/78 H1N1 infection after treatment with aspirin or amantadine. Antimicrob Agents Chemother (1983) 1.16
Nosocomial respiratory syncytial viral infections. Should gowns and masks be used? Am J Dis Child (1981) 1.15
Effect of selective complement deficiency on the rate of neutralization of enveloped viruses by human sera. J Immunol (1977) 1.14
Control of nosocomial respiratory syncytial viral infections. Pediatrics (1978) 1.13
Lymphocytic choriomeningitis in university hospital personnel. Clinical features. Am J Med (1975) 1.12
Temperature-sensitive mutants of influenza A virus: evaluation of the A/Victoria/75-ts-1A2 temperature-sensitive recombinant virus in seronegative adult volunteers. Infect Immun (1979) 1.11
In vivo inhibition of respiratory syncytial virus by ribavirin. Antimicrob Agents Chemother (1982) 1.10
The sedimentation and antigenic properties of proteins in nasal and other external secretions. J Immunol (1966) 1.10
Resuscitation: how do we decide? A prospective study of physicians' preferences and the clinical course of hospitalized patients. JAMA (1986) 1.10
Atraumatic biopsy of nasal mucosa. Arch Otolaryngol (1969) 1.10
Interferon production by human mononuclear leukocytes: differences between respiratory syncytial virus and influenza viruses. Infect Immun (1981) 1.09
Influenza vaccination of patients with systemic lupus erythematosus. Ann Intern Med (1978) 1.08
Therapeutic effects of aerosolized amantadine in naturally acquired infection due to influenza A virus. J Infect Dis (1980) 1.08
Transmission of cytomegalovirus infection with renal allograft. Kidney Int (1975) 1.08
Comparative study of reactogenicity and immunogenicity of influenza A/New Jersey/8/76 (Hsw1N1) virus vaccines in normal volunteers. J Infect Dis (1977) 1.08
Outbreak of lymphocytic choriomeningitis virus infections in medical center personnel. Am J Epidemiol (1975) 1.07
Parainfluenza viral infections in children: correlation of shedding with clinical manifestations. J Pediatr (1977) 1.04
Pulmonary mechanics after uncomplicated influenza A infection. Am Rev Respir Dis (1976) 1.03
Nosocomial viral infections: I. Epidemiology and significance. Infect Control (1982) 1.02
The leukocyte response during viral respiratory illness in man. Ann Intern Med (1966) 1.02
Effect of induced interferon in experimental rhinovirus infections in volunteers. Infect Immun (1974) 1.01
Human macrophage and lymphocyte responses to mitogen stimulation after exposure to influenza virus, ascorbic acid, and hyperthermia. J Immunol (1979) 1.00
The childbearing center: an alternative birth setting. Obstet Gynecol (1979) 1.00
Herpes simplex virus pneumonia. Occurrence in an allotransplanted lung. JAMA (1969) 0.99
Different antiviral spectra of human macrophage interferon activities. Nature (1983) 0.98
Influenza A/Brazil/78(H1N1) infection in the elderly. Am Rev Respir Dis (1981) 0.98
Parenteral inactivated rhinovirus vaccine: minimal protective effect. Proc Soc Exp Biol Med (1972) 0.98
Human alveolar macrophage regulation of lymphocyte proliferation. Am Rev Respir Dis (1986) 0.98
Immunization of elderly people with two doses of influenza vaccine. J Clin Microbiol (1987) 0.96
Suppressed expression of ICAM-1 and LFA-1 and abrogation of leukocyte collaboration after exposure of human mononuclear leukocytes to respiratory syncytial virus in vitro. Comparison with exposure to influenza virus. J Clin Invest (1991) 0.96
Expression of viral antigens after infection of human lymphocytes, monocytes, and macrophages with influenza virus. J Infect Dis (1985) 0.96
Antibody to rhinovirus in human sera. II. Heterotypic responses. Proc Soc Exp Biol Med (1968) 0.94